Company / R&D per Share
Bone Biologics Corp R&D per Share History
FY2017-FY2020 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest R&D per Share
$0.04
FY2020
5-year range
$0.00 / $0.33
FY2017-FY2020
Trend
+803.5%
vs FY2019
Sector context
Sector data unavailable
Latest sector comparison
What the data says
R&D per Share changed +803% YoY in FY2020, a notable deviation from the 3-year average annual change of +262%.
Based on SEC 10-K filings.
0.04 in FY2020 with a 3-year CAGR of -41.7%.
Declined from $0.33 to $0.04 over the past 2 years.
R&D per Share over time
Growth rates
- 3-Year CAGR
- -41.7%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2020, r&d per share increased 803.5% year-over-year.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | R&D per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2020 | $0.04 | +803.5% |
| FY2019 | $0.00 | -98.8% |
| FY2018 | $0.33 | +81.5% |
| FY2017 | $0.18 | - |
As of FY2020 · SEC 10-K · Updated Jun 28, 2026